KeyNeurotek Pharmaceuticals
Latest round
- Series C
Last raised
- Apr 2009
Total raised
- $11M
Investors
- 3
About KeyNeurotek Pharmaceuticals
KeyNeurotek Pharmaceuticals AG specializes in neurotechnology, offering advanced solutions for cognitive performance.20 mn.KeyNeurotek Pharmaceuticals AG specializes in innovative neurotechnology solutions designed to enhance cognitive performance and mental well-being. The company’s core offerings include advanced neurofeedback systems that utilize real-time brainwave monitoring to facilitate training and rehabilitation. These systems are particularly beneficial for applications in psychological therapy, cognitive enhancement, and rehabilitation for conditions such as ADHD or anxiety disorders. KeyNeurotek's products have been implemented in clinical settings, educational institutions, and wellness centers, catering to a diverse clientele that includes healthcare professionals and individual consumers seeking self-improvement and therapeutic solutions.20. The company generates revenue through a combination of direct sales and subscription-based models. KeyNeurotek offers its neurofeedback systems to clients such as clinics and wellness centers, who purchase the technology outright or enter into partnership agreements for ongoing usage and support services. Typical transactions involve an upfront payment for the hardware, complemented by a recurring subscription for software updates, training, and customer support. Additionally, flagship products and services, which are integral to their offering, come with tailored pricing plans that reflect the specific needs of their diverse clientele.KeyNeurotek Pharmaceuticals AG is actively developing new neurofeedback products aimed at expanding its market presence. The company has plans to launch these new offerings by the end of the upcoming fiscal year, targeting both European and North American markets for expansion.
Who invested in KeyNeurotek Pharmaceuticals
3 investors across 1 round
See all investors in KeyNeurotek Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Apr 7, 2009
Amount
$11M
Investors
Questions about KeyNeurotek Pharmaceuticals
Who invested in KeyNeurotek Pharmaceuticals?
KeyNeurotek Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KeyNeurotek Pharmaceuticals raised?
KeyNeurotek Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KeyNeurotek Pharmaceuticals last raise money?
KeyNeurotek Pharmaceuticals's most recent round on record is a Series C, in Apr 2009.
What does KeyNeurotek Pharmaceuticals do?
KeyNeurotek Pharmaceuticals AG specializes in neurotechnology, offering advanced solutions for cognitive performance.
Where is KeyNeurotek Pharmaceuticals headquartered?
KeyNeurotek Pharmaceuticals is headquartered in Magdeburg, Germany.
Which VCs invest in companies like KeyNeurotek Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at KeyNeurotek Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like KeyNeurotek Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.